Clin2
NCT07217691Possibly a fitNot yet recruiting

Better valve placement for severe aortic stenosis

Aortic StenosisTrans-catheter Aortic Valve ImplantationCommissural Alignment

Part of Heart & circulation clinical trials.

This trial tests a new way to position the Evolut FX+ valve in people with severe aortic stenosis. The goal is to improve how the valve lines up with your own heart structure, which may help it work better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have severe aortic stenosis and your heart team has recommended a valve replacement procedure (TAVI).
  • You are 65 years old or older.
  • Your heart team plans to use the Evolut FX+ self-expanding valve for your procedure.
  • You do not have severe blood vessel disease in your legs that would block the insertion of the valve through your leg artery.
  • You have not had a previous aortic valve replacement, and your aortic valve has two flaps (bicuspid) instead of three.
  • Your kidney function is not severely reduced (estimated glomerular filtration rate is 30 or higher).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06743568Recruiting
Comparing new valves for tight aortic valve in enlarged aorta

This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.

Beijing, Beijing Municipality
NCT05886517Recruiting
Transcatheter aortic valve in patients too high-risk for surgery

This trial looks at placing a new aortic valve through the groin (transfemoral) without needing on-site heart surgery for people who are considered very high risk for standard open-heart valve surgery. It aims to measure early outcomes to see how safe and effective this approach is for frail or complex patients.

Acquaviva delle Fonti, Bari
NCT07343674Recruiting
Studying a new heart valve replacement system for aortic stenosis

This trial is testing a new heart valve system (Medtronic Evolut FX+) for people with severe aortic stenosis—a condition where the heart's main valve is narrowed. The study aims to see how well the valve works and improve your care journey.

Coimbra, Coimbra District
NCT04076150Recruiting
Testing a new valve placed through a blood vessel

This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.

Krakow
NCT07042529Recruiting
Optimizing valve placement during TAVI

This trial is testing a better way to position a new heart valve during a TAVI procedure. The goal is to help the valve work as well as possible for people with severe aortic stenosis.

Aalst
NCT07545369Not yet recruiting
Comparing Two New Heart Valve Replacement Devices

This trial compares two of the newest transcatheter aortic valve devices—the SAPIEN 3 Ultra Resilia and Evolut FX—to see which works better for patients with severe aortic stenosis (a narrowed aortic valve). Both devices are placed through a catheter without open surgery.

Asyut, Assiut Governorate

Hear when a new Aortic Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.